APA (7th ed.) Citation

E, D., E, N., V, N., JA, H., L, M., E, N., . . . LM, S. (2022). Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer. Therapeutic advances in medical oncology, 14, 17588359221119370. https://doi.org/10.1177/17588359221119370

Chicago Style (17th ed.) Citation

E, Denault, et al. "Immunogenicity of SARS-CoV-2 Vaccines in Patients with Breast Cancer." Therapeutic Advances in Medical Oncology 14 (2022): 17588359221119370. https://doi.org/10.1177/17588359221119370.

MLA (9th ed.) Citation

E, Denault, et al. "Immunogenicity of SARS-CoV-2 Vaccines in Patients with Breast Cancer." Therapeutic Advances in Medical Oncology, vol. 14, 2022, p. 17588359221119370, https://doi.org/10.1177/17588359221119370.